Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Geburtshilfe Und Frauenheilkunde
|
March 5, 2016
ABC3 Consensus Commented from the Perspective of the German Guidelines: Third International Consensus Conference for Advanced Breast Cancer (ABC3), Lisbon, 07. 11. 2015
M Untch, D Augustin, J Ettl, et al.
Geburtshilfe Und Frauenheilkunde
|
April 29, 2014
Chemotherapy for 70-Year-Old Women with Breast Cancer in Germany: A Survey by the German Breast Group
J Barinoff, A Traut, D Bauerschlag, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 26, 2017
Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial
V Möbus, C Jackisch, H J Lück, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2017
German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients
V Möbus, G von Minckwitz, C Jackisch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 20, 2004
Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial
M Untch, H Eidtmann, A du Bois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 9, 2011
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer--outcome on prognosis
M Untch, G von Minckwitz, G E Konecny, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 10, 2011
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel ± darbepoetin alfa in primary breast cancer--results at the time of surgery
M Untch, P A Fasching, G E Konecny, et al.
Zentralblatt Fur Gynakologie
|
February 2, 2006
[Diagnosis and treatment of malignant ovarian tumors 2005: recommendations of the Kommission Ovar of the AGO]
B Schmalfeldt, A du Bois, A Burges, et al.
Geburtshilfe Und Frauenheilkunde
|
July 14, 2015
Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015)
M Untch, N Harbeck, J Huober, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 1999
Advanced epithelial ovarian cancer: 1998 consensus statements
J S Berek, K Bertelsen, A du Bois, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Geburtshilfe Und Frauenheilkunde
|
March 5, 2016
ABC3 Consensus Commented from the Perspective of the German Guidelines: Third International Consensus Conference for Advanced Breast Cancer (ABC3), Lisbon, 07. 11. 2015
M Untch, D Augustin, J Ettl, et al.
Geburtshilfe Und Frauenheilkunde
|
April 29, 2014
Chemotherapy for 70-Year-Old Women with Breast Cancer in Germany: A Survey by the German Breast Group
J Barinoff, A Traut, D Bauerschlag, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 26, 2017
Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial
V Möbus, C Jackisch, H J Lück, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2017
German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients
V Möbus, G von Minckwitz, C Jackisch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 20, 2004
Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial
M Untch, H Eidtmann, A du Bois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 9, 2011
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer--outcome on prognosis
M Untch, G von Minckwitz, G E Konecny, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 10, 2011
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel ± darbepoetin alfa in primary breast cancer--results at the time of surgery
M Untch, P A Fasching, G E Konecny, et al.
Zentralblatt Fur Gynakologie
|
February 2, 2006
[Diagnosis and treatment of malignant ovarian tumors 2005: recommendations of the Kommission Ovar of the AGO]
B Schmalfeldt, A du Bois, A Burges, et al.
Geburtshilfe Und Frauenheilkunde
|
July 14, 2015
Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015)
M Untch, N Harbeck, J Huober, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 1999
Advanced epithelial ovarian cancer: 1998 consensus statements
J S Berek, K Bertelsen, A du Bois, et al.
Page
of 5